Patent 7987002

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

Active provider: Google · gemini-2.5-flash

Proceedings on file (0)

All PTAB activity →

AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.

No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.

PTAB challenges

AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.

✓ Generated

Proceedings overview

There are no AIA trial proceedings on file for US Patent 7987002 as of the most recent ingest from the USPTO ODP API. A web search did not surface any additional PTAB proceedings. This means that all claims of the patent remain untested in an AIA trial context, and a defendant currently facing assertion of this patent would approach it with the understanding that its validity has not been challenged before the PTAB.

Strategic summary

As of the current date, US Patent 7987002 has no record of AIA trial proceedings at the PTAB. This implies that all claims (1-29) of the patent are currently UNTESTED through inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) proceedings.

The absence of PTAB challenges for a patent that has been in force since 2011 is noteworthy, especially given its "Active" legal status and identified litigation in various District Courts. Typically, patents asserted in litigation, particularly those involved in multiple cases, often become targets for AIA trial petitions. This lack of PTAB activity could mean several things: either potential petitioners have not found strong prior art that meets the institution threshold, or the patent's claims are considered robust against IPR/PGR challenges, or the asserted claims are not considered significant enough to warrant a PTAB challenge, or the patent has not yet been asserted in a context that typically draws PTAB filings (e.g., against large tech companies).

For a defendant currently being asserted against, the entire landscape of prior-art grounds is still available. There are no estoppel bars under § 315(e)(2) from previous PTAB proceedings. Therefore, any prior art grounds (e.g., under § 102 or § 103) that could be raised in an IPR are still viable for a new petition. The litigation history, particularly the filings in the Texas Eastern District Court, suggests active assertion, which might eventually lead to PTAB challenges if defendants decide to pursue that route.

Recommended next steps

Given the absence of any PTAB activity for US Patent 7987002:

  • For a potential defendant: Consider a comprehensive prior art search to evaluate the strength of a potential IPR or PGR petition against the asserted claims. The absence of previous challenges means there is no existing PTAB record to leverage, making the initial prior art investigation and petition drafting critical.
  • Monitor for future filings: Stay vigilant for any new IPR, PGR, or CBM petitions filed against US7987002, as the patent's active litigation status might change this landscape in the future.
  • The absence of PTAB activity itself is a signal: well-asserted patents eventually attract IPRs. The fact that this patent, which has litigation history, has not yet faced a PTAB challenge suggests that potential challengers either have not found compelling grounds or have chosen alternative litigation strategies.

Proceedings overview

The USPTO ODP API reports no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method) on file for US Patent 7987002. However, web search has identified one ex parte reexamination proceeding concerning this patent. While an ex parte reexamination is distinct from an AIA trial, its institution indicates that "substantial new questions of patentability" have been found for the challenged claims. This means the patent's claims are currently under re-evaluation at the USPTO.

Ex Parte Reexamination Control No. 90/019,867 — Unified Patents v. Longhorn Automotive Group LLC

  • Type: Ex Parte Reexamination (Note: This is not an AIA trial proceeding like IPR, PGR, or CBM, but an administrative reexamination by the USPTO.)
  • Filed: 2025-02-26
  • Status: Institution Granted (Central Reexamination Unit granted Unified Patents' request on 2025-04-22, finding substantial new questions of patentability on the challenged claims.)
  • Judge panel: N/A (Ex parte reexaminations are conducted by a USPTO examiner, not a PTAB judge panel).
  • Petition grounds: Unified Patents filed the reexamination request. The specific claims challenged are not explicitly listed in the public summary, but the CRU found "substantial new questions of patentability" on "the challenged claims." Prior art identified by Unified Patents that led to "winning prior art" on this patent includes US 20080040477, US 6324607, US 6529589, and WO 2002013036. The statutory basis is typically anticipation (§ 102) and/or obviousness (§ 103) based on prior art.
  • Institution decision: Instituted on 2025-04-22. The Central Reexamination Unit (CRU) granted Unified Patents' request, determining that there are "substantial new questions of patentability" on the challenged claims of the patent.
  • Final Written Decision (if issued): Not yet issued, as the reexamination was recently instituted.
  • Settlement / termination: N/A (This is a USPTO-initiated proceeding, not a party-negotiated settlement).
  • Appeal: Not yet applicable. Decisions in ex parte reexamination can be appealed to the PTAB and then to the Federal Circuit, but only after a final decision by the examiner.
  • Defensive value: The institution of this ex parte reexamination is a significant development. A finding of "substantial new questions of patentability" means the USPTO examiner believes there's a good chance the challenged claims may be invalid over the cited prior art. This places a cloud over the validity of those claims and could significantly impact ongoing or future infringement assertions. While not an AIA trial, it serves as a strong signal of potential invalidity.

Strategic summary

While there are no AIA trial proceedings (IPR, PGR, CBM) on file for US Patent 7987002, an ex parte reexamination (Control No. 90/019,867) was filed by Unified Patents on 2025-02-26 and subsequently instituted on 2025-04-22. The institution indicates that the Central Reexamination Unit found "substantial new questions of patentability" regarding the challenged claims. This means the validity of some claims, although not specified in the public summaries, is now officially under review by a USPTO examiner.

Currently, all claims of US7987002 remain untested in the context of AIA trial proceedings. However, the ex parte reexamination directly challenges the patent's validity. If the reexamination ultimately results in cancellation of claims, those claims will be CANCELED. If claims are confirmed, they will be SUSTAINED (though potentially with amendments). The claims not addressed in the reexamination would remain UNTESTED.

The estoppel landscape differs for ex parte reexamination compared to AIA trials. A third-party requestor in an ex parte reexamination is generally not subject to the same estoppel provisions as petitioners in IPRs/PGRs. This means that if a defendant is being asserted against, even if Unified Patents challenged certain claims, that defendant might still be able to raise similar or different prior-art grounds in district court litigation or a new IPR (if eligible), provided they are not a privy to Unified Patents or have not previously raised and lost on those grounds in a different forum.

Unified Patents, a defensive aggregator, initiated this reexamination. Their involvement signals a concerted effort by the industry to challenge patents asserted by Non-Practicing Entities (NPEs) like Longhorn Automotive Group LLC. The patent is currently being asserted against several major automotive companies, including Volkswagen, Mazda, Hyundai, Mitsubishi, Volvo, and Nissan.

Recommended next steps

  • For a defendant facing assertion of US7987002: Immediately investigate the specifics of Ex Parte Reexamination Control No. 90/019,867. Access the reexamination request and institution decision through the USPTO's public PAIR system or Unified Patents' portal (https://portal.unifiedpatents.com/exparte/[90019867](/patent/90019867)) to identify precisely which claims are challenged and what prior art is being used.
  • Monitor the reexamination: Track the progress of the ex parte reexamination closely. Any office actions, responses, or examiner's determinations could provide valuable insights into the patent's validity.
  • Evaluate impact on ongoing litigation: The finding of "substantial new questions of patentability" could be used in district court litigation to argue for a stay of proceedings or to challenge the validity of the asserted claims.
  • Consider further action: Depending on the outcome of the reexamination, and the specific claims being asserted, a defendant might still consider filing an IPR or PGR (if statutory requirements are met) for any claims not covered by the reexamination or if new prior art is discovered.

Generated 5/16/2026, 6:46:22 PM